Treace Medical Concepts (TMCI) 2025 Investor Day September 03, 2025 09:00 AM ET Company ParticipantsJohn Treace - CEO, Founder & ChairmanWilliam DeCarbo - Podiatric SurgeonMark Easley - Associate Professor - Orthopaedic SurgeryA. Holly Johnson - Orthopedic surgeonJonathan Kaplan - Associate Professor - Orthopaedic SurgerySean Scanlan - Chief Innovation OfficerJohn TreaceGood morning, everybody. We're going to go ahead and get started. Thanks for joining us today for Treace Medical Concepts' Investor Day eve ...

PONTE VEDRA, Fla., May 08, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship Lapiplasty® and Adductoplasty® Procedures, today reported financial results for the first quarter ended March 31, 2025. Recent Highlights Generated revenue of $52.6 million in first quarter 2025 representing growth of 3% over the same pe ...